These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 32961514

  • 1. The Effect of Intradermal Botulinum Toxin a injections on painful diabetic polyneuropathy.
    Taheri M, Sedaghat M, Solhpour A, Rostami P, Safarpour Lima B.
    Diabetes Metab Syndr; 2020; 14(6):1823-1828. PubMed ID: 32961514
    [Abstract] [Full Text] [Related]

  • 2. The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy.
    Ghasemi M, Ansari M, Basiri K, Shaigannejad V.
    J Res Med Sci; 2014 Feb; 19(2):106-11. PubMed ID: 24778662
    [Abstract] [Full Text] [Related]

  • 3. [Botulinum toxin and painful peripheral neuropathies: what should be expected?].
    Ranoux D.
    Rev Neurol (Paris); 2011 Jan; 167(1):46-50. PubMed ID: 21194720
    [Abstract] [Full Text] [Related]

  • 4. The Efficacy of Intradermal Injection of Botulinum Toxin Type-A on Painful Diabetic Neuropathy: A Systematic Review.
    Bayat M, Raeissadat SA, Hojjati F, Faghani P, Naseri N, Ghafari V.
    Anesth Pain Med; 2023 Oct; 13(5):e136260. PubMed ID: 38476988
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Botulinum Toxin Type A for Diabetic Peripheral Neuropathy Pain: A Systematic Review and Meta-Analysis.
    Wang C, Zhang Q, Wang R, Xu L.
    J Pain Res; 2021 Oct; 14():3855-3863. PubMed ID: 34938114
    [Abstract] [Full Text] [Related]

  • 8. Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis.
    Lakhan SE, Velasco DN, Tepper D.
    Pain Med; 2015 Sep; 16(9):1773-80. PubMed ID: 25800040
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study.
    Grimstad Ø, Kvammen BØ, Swartling C.
    Am J Clin Dermatol; 2020 Oct; 21(5):741-748. PubMed ID: 32761500
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT.
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D, Attal N, Morain F, Bouhassira D.
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [Abstract] [Full Text] [Related]

  • 18. Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study.
    Babcock MS, Foster L, Pasquina P, Jabbari B.
    Am J Phys Med Rehabil; 2005 Sep; 84(9):649-54. PubMed ID: 16141740
    [Abstract] [Full Text] [Related]

  • 19. The effects of botulinum toxin type A injection on pain symptoms, quality of life, and sleep quality of patients with diabetic neuropathy: A randomized double-blind clinical trial.
    Salehi H, Moussaei M, Kamiab Z, Vakilian A.
    Iran J Neurol; 2019 Jul 06; 18(3):99-107. PubMed ID: 31749930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.